Early-Phase Interventional Trials in Oral Cancer Prevention.
Ontology highlight
ABSTRACT: The increasing breadth of molecular targets, promise of immune-targeted therapies and repurposed agents have heightened interest in cancer prevention. While, to date, testing of oral cancer chemoprevention strategies has failed to deliver therapeutic agents for routine clinical practice, there remains an urgent need for further clinical research to overcome this hurdle. Patients at the greatest risk of disease stand to benefit the most from inclusion in clinical trials; therefore, there is a need to carefully define this population using validated clinical and molecular markers. Safety, tolerability and the efficacy of interventions is assessed through carefully selected endpoints. These endpoints may include pharmacodynamic, clinical, histological and on-target molecular modifications as
SUBMITTER: McCarthy C
PROVIDER: S-EPMC8345124 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA